DCM Shriram Limited share price

NSE: DCMSHRIRAM · ISIN INE499A01024

Key numbers

Market cap
₹ 15,088 Cr
Current price
₹ 974.30
52-week high / low
₹ 1,409 / 945
Stock P/E
10.6
Book value
₹ 482.5
Dividend yield
1.64%
ROCE
11.5%
ROE
11.6%
Debt to equity
0.38
Sales growth (3 yrs)
5.5%
Profit growth (3 yrs)
-2.1%
1-year return
-19.5%

About DCM Shriram Limited

DCM Shriram Limited, together with its subsidiaries, engages in agri-rural, chemicals and vinyl, and value added businesses in India and internationally. It operates through Chemicals and Vinyl, Sugar and Ethanol, Fenesta Building System, Shriram Farm solutions, Fertiliser, Bioseed, and Others segments. The company manufactures poly-vinyl chloride, PVC compounds, carbide, and chlor alkali products; sodium hydroxide, chlorine, hydrogen, sodium hypochlorite, hydrochloric acid, caustic soda, caustic, lye and urea, calcium carbide, aluminium chloride, bleaching powder, and UPVC and aluminium doors and windows; and sugar and ethanol. It is also involved in co-generation and sale of power; provision of plant nutrients, seeds, and pesticides; production of hybrid seeds; offers cement, rural retail, and plaster of paris; operates fuel outlets. The company was incorporated in 1989 and is based in New Delhi, India. DCM Shriram Limited operates as a subsidiary of Sumant Investments Pvt Ltd.

Quarterly results

Consolidated figures in ₹ crores

Mar 2025Jun 2025Dec 2025Mar 2026Jun 2026
Sales2,8403,2493,7863,1713,548
Operating profit405304532353337
Net profit179113212370693
EPS (₹)11.477.2713.5923.7144.42

Concall summary (2026-08-05)

AI summary of the earnings call transcript · tone: Positive · source document

Guidance & outlook

  • The global sugar market is expected to shift into a deficit in the year 2026-27 season, with demand projected to exceed production by around 0.7 million metric tons, compared to a surplus of around 2.5 million metric tons last year.
  • Net revenues, net of excise duty, for Q1 FY27 were at INR3,564 crore versus INR3,262 crore in Q1 FY26, an increase of 9% year-on-year.

Growth & demand

  • As part of our growth strategy, the business strengthened alliances, launched four varieties from our in-house R&D pipeline, reinforcing our innovation-led growth agenda and creating a platform for further scale-up.
  • Fenesta Building Systems revenue increased 22% year-on-year, led by higher volumes across both the project and retail segments.

Margins & costs

  • Capacity utilization during the quarter stood at 82%.
  • On profitability, PBDIT rose by 24% to INR274 crore, aided by higher volumes and better realizations in the advanced materials, though partially offset by elevated input costs.

Capex & expansion

  • The plant has delivered a healthy operating performance with capacity utilization at around 85%.
  • Our epichlorohydrin and epoxy plants are currently operating at around 70% capacity utilization each, reflecting continuous ramp-up and stable operations.

Balance sheet & cash

  • Today, our strong operating cash flows are fully funding our capital investments while preserving our agility to capture organic and inorganic growth opportunities.
  • The company's net debt is INR1,649 crore as on June 30, 2026, as against INR1,481 crore as on June 30, 2025.

Peers in Conglomerates

Data for information only, not investment advice. Prices end of day.